{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T20:24:18Z","timestamp":1685651058846},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ypmed.2005.11.016","type":"journal-article","created":{"date-parts":[[2006,1,7]],"date-time":"2006-01-07T12:21:42Z","timestamp":1136636502000},"page":"313-315","source":"Crossref","is-referenced-by-count":9,"title":["Disparities among the disadvantaged: Variation in lipid management in the Ohio Medicaid program"],"prefix":"10.1016","volume":"42","author":[{"given":"David","family":"Litaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siran","family":"Koroukian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Frolkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Aron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2005.11.016_bib1","first-page":"52","article-title":"Disparities in premature coronary heart disease mortality by region and urbanicity among black and white adults ages 35\u201364, 1985\u20131995","volume":"115","author":"Barnett","year":"2000","journal-title":"Public Health Rep."},{"key":"10.1016\/j.ypmed.2005.11.016_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S","article-title":"Disparities in cancer diagnosis and survival","volume":"91","author":"Bradley","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2005.11.016_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"Medical Research Council\/British Heart Foundation Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ypmed.2005.11.016_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archinte.162.12.1395","article-title":"Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study","volume":"162","author":"Lemaitre","year":"2002","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.ypmed.2005.11.016_bib5","series-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","first-page":"O1","author":"National Cholesterol Education Program","year":"1993"},{"key":"10.1016\/j.ypmed.2005.11.016_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archinte.160.4.459","article-title":"The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals","volume":"160","author":"Pearson","year":"2000","journal-title":"Arch. Int. Med."},{"issue":"13","key":"10.1016\/j.ypmed.2005.11.016_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.161.13.1621","article-title":"Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey","volume":"161","author":"Qureshi","year":"2001","journal-title":"Arch. Int. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2005.11.016_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/oxfordjournals.aje.a115198","article-title":"Use of Medicaid data for pharmacoepidemiology","volume":"129","author":"Ray","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2005.11.016_bib9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2005.11.016_bib10","series-title":"Epidemiologic Reviews","first-page":"87","article-title":"Use of automated databases for pharmacoepidemiological research","author":"Strom","year":"1990"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743505002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743505002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T06:29:33Z","timestamp":1547879373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743505002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0091743505002288"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2005.11.016","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}